LAS VEGAS, Oct. 31, 2019 /PRNewswire/ — GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce that on October 23(rd) Mr. Edmond DeFrank joined its Board of Directors, filling a vacant seat. Mr. DeFrank is an attorney in the cannabis sector with deep expertise in patents and intellectual property. Mr. DeFrank brings a host of skills and experience beneficial to the Company.
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
VANCOUVER, Oct. 31, 2019 /CNW/ – Geyser Brands Inc. (formerly Kanzen Capital Corp.) (TSX-V: GYSR) (“Geyser Brands” or the “Company) is pleased to announce the appointments of advertising legend, Mr. Frank Palmer, Mr. Carlo Valente, a senior finance, capital markets and M&A expert, and Mr. Timothy Murphy, an international lawyer and business executive as Independent Directors, effective October 30, 2019.
NEW YORK, Oct. 30, 2019 /PRNewswire/ — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) continues investigating claims on behalf of investors who purchased shares of Sundial Growers Inc. (“Sundial” or the “Company”), a “craft pioneering cannabis” company.
EDMONTON, AB, Oct. 30, 2019 /CNW/ – Dynaleo Inc. (“Dynaleo”), an Edmonton, AB based manufacturer of cannabis infused gummies for the adult use market, is pleased to announce the completion of the first phase of its high-volume manufacturing facility. “With construction of Phase 1 now complete, we have submitted our application for a Standard Processing License to Health Canada. We are on track to finish the entire 26,000 square foot facility in January 2020, and upon receiving the required licenses from Health Canada, we anticipate selling our products through licensed Canadian retailers shortly thereafter,” said Executive Chairman Michael Krestell. “We are aiming to be Canada’s highest volume manufacturer of CBD and THC infused adult chews, and completion of Phase 1 is a significant milestone on the way to achieving this.”
VANCOUVER, Oct. 30, 2019 /PRNewswire/ – CANNAMERICA BRANDS CORP. (“CannAmerica” or the “Company”) (CSE: CANA) (OTCQB: CNNXF) is pleased to announce that on October 28, 2019, it entered into a long-term licensing agreement (the “Agreement”) and brand partnership with Canna Provisions Inc. (“the Licensee”) under which the Licensee will have an exclusive license to manufacture and distribute CannAmerica branded cannabis infused gummy products and Live Labs branded concentrate products (the “Licensed Products”) in the Commonwealth of Massachusetts.
/THIS NEWS RELEASE, PROVIDED PURSUANT TO APPLICABLE CANADIAN REQUIREMENTS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION OR APPLICABLE EXEMPTION FROM REGISTRATION REQUIREMENTS./
/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES/
The company’s newest storefront expands patient access to the state’s widest-ranging medical cannabis inventory to patients in the Panhandle
SGS Colombia SAS, in Collaboration with Ikänik, Seeks To Enhance and Harmonize International Medicinal Cannabis Production Standards